nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—ABCC11—Conjugated Estrogens—osteoporosis	0.121	0.169	CbGbCtD
Indomethacin—SLC10A1—Ethinyl Estradiol—osteoporosis	0.082	0.114	CbGbCtD
Indomethacin—SLC10A1—Conjugated Estrogens—osteoporosis	0.0602	0.084	CbGbCtD
Indomethacin—PTGS2—Risedronate—osteoporosis	0.0419	0.0585	CbGbCtD
Indomethacin—ABCC1—Zoledronate—osteoporosis	0.0369	0.0515	CbGbCtD
Indomethacin—ABCC3—Conjugated Estrogens—osteoporosis	0.0334	0.0467	CbGbCtD
Indomethacin—SLC22A11—Conjugated Estrogens—osteoporosis	0.0275	0.0383	CbGbCtD
Indomethacin—ABCC4—Conjugated Estrogens—osteoporosis	0.0256	0.0357	CbGbCtD
Indomethacin—SLC22A11—Estradiol—osteoporosis	0.0241	0.0336	CbGbCtD
Indomethacin—UGT1A1—Estradiol—osteoporosis	0.0219	0.0306	CbGbCtD
Indomethacin—ABCC2—Ethinyl Estradiol—osteoporosis	0.0207	0.0289	CbGbCtD
Indomethacin—ABCC1—Conjugated Estrogens—osteoporosis	0.0205	0.0287	CbGbCtD
Indomethacin—ALB—Estropipate—osteoporosis	0.02	0.028	CbGbCtD
Indomethacin—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0183	0.0256	CbGbCtD
Indomethacin—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0173	0.0241	CbGbCtD
Indomethacin—SLCO1A2—Estradiol—osteoporosis	0.0161	0.0225	CbGbCtD
Indomethacin—SLC22A8—Conjugated Estrogens—osteoporosis	0.016	0.0223	CbGbCtD
Indomethacin—ABCC2—Conjugated Estrogens—osteoporosis	0.0152	0.0212	CbGbCtD
Indomethacin—SLCO1B1—Estradiol—osteoporosis	0.0152	0.0212	CbGbCtD
Indomethacin—SLC22A8—Estradiol—osteoporosis	0.014	0.0196	CbGbCtD
Indomethacin—SLC22A6—Conjugated Estrogens—osteoporosis	0.0111	0.0155	CbGbCtD
Indomethacin—CYP2C9—Estropipate—osteoporosis	0.0108	0.0151	CbGbCtD
Indomethacin—ALB—Estradiol—osteoporosis	0.00832	0.0116	CbGbCtD
Indomethacin—ABCB1—Ethinyl Estradiol—osteoporosis	0.00675	0.00942	CbGbCtD
Indomethacin—CYP2C19—Cholecalciferol—osteoporosis	0.00669	0.00934	CbGbCtD
Indomethacin—CYP2C9—Cholecalciferol—osteoporosis	0.00556	0.00776	CbGbCtD
Indomethacin—CYP2C19—Estradiol—osteoporosis	0.00539	0.00753	CbGbCtD
Indomethacin—ABCB1—Conjugated Estrogens—osteoporosis	0.00496	0.00692	CbGbCtD
Indomethacin—CYP2C9—Estradiol—osteoporosis	0.00448	0.00626	CbGbCtD
Indomethacin—ABCB1—Estradiol—osteoporosis	0.00435	0.00607	CbGbCtD
Indomethacin—Urticaria—Calcitriol—osteoporosis	0.000152	0.000874	CcSEcCtD
Indomethacin—Hepatitis—Estradiol—osteoporosis	0.000152	0.000872	CcSEcCtD
Indomethacin—Haemorrhage—Estradiol—osteoporosis	0.000152	0.000872	CcSEcCtD
Indomethacin—Palpitations—Zoledronate—osteoporosis	0.000152	0.000871	CcSEcCtD
Indomethacin—Abdominal pain—Calcitriol—osteoporosis	0.000152	0.000869	CcSEcCtD
Indomethacin—Body temperature increased—Calcitriol—osteoporosis	0.000152	0.000869	CcSEcCtD
Indomethacin—Angioedema—Conjugated Estrogens—osteoporosis	0.000151	0.000867	CcSEcCtD
Indomethacin—Shock—Pamidronate—osteoporosis	0.000151	0.000866	CcSEcCtD
Indomethacin—Loss of consciousness—Zoledronate—osteoporosis	0.000151	0.000866	CcSEcCtD
Indomethacin—Hypersensitivity—Estropipate—osteoporosis	0.000151	0.000863	CcSEcCtD
Indomethacin—Thrombocytopenia—Pamidronate—osteoporosis	0.00015	0.000862	CcSEcCtD
Indomethacin—Vomiting—Etidronic acid—osteoporosis	0.00015	0.000861	CcSEcCtD
Indomethacin—Tachycardia—Pamidronate—osteoporosis	0.00015	0.000859	CcSEcCtD
Indomethacin—Rash—Etidronic acid—osteoporosis	0.000149	0.000854	CcSEcCtD
Indomethacin—Convulsion—Zoledronate—osteoporosis	0.000149	0.000854	CcSEcCtD
Indomethacin—Dermatitis—Etidronic acid—osteoporosis	0.000149	0.000853	CcSEcCtD
Indomethacin—Vertigo—Conjugated Estrogens—osteoporosis	0.000149	0.000852	CcSEcCtD
Indomethacin—Hyperhidrosis—Pamidronate—osteoporosis	0.000148	0.000851	CcSEcCtD
Indomethacin—Syncope—Conjugated Estrogens—osteoporosis	0.000148	0.000851	CcSEcCtD
Indomethacin—Hypertension—Zoledronate—osteoporosis	0.000148	0.000851	CcSEcCtD
Indomethacin—Hypersensitivity—Alendronate—osteoporosis	0.000148	0.00085	CcSEcCtD
Indomethacin—Headache—Etidronic acid—osteoporosis	0.000148	0.000848	CcSEcCtD
Indomethacin—Asthenia—Estropipate—osteoporosis	0.000147	0.000841	CcSEcCtD
Indomethacin—Anorexia—Pamidronate—osteoporosis	0.000146	0.000839	CcSEcCtD
Indomethacin—Chest pain—Zoledronate—osteoporosis	0.000146	0.000839	CcSEcCtD
Indomethacin—Palpitations—Conjugated Estrogens—osteoporosis	0.000146	0.000838	CcSEcCtD
Indomethacin—Insomnia—Risedronate—osteoporosis	0.000146	0.000837	CcSEcCtD
Indomethacin—Anxiety—Zoledronate—osteoporosis	0.000146	0.000836	CcSEcCtD
Indomethacin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000145	0.000834	CcSEcCtD
Indomethacin—Paraesthesia—Risedronate—osteoporosis	0.000145	0.000831	CcSEcCtD
Indomethacin—Pruritus—Estropipate—osteoporosis	0.000145	0.000829	CcSEcCtD
Indomethacin—Discomfort—Zoledronate—osteoporosis	0.000144	0.000829	CcSEcCtD
Indomethacin—Asthenia—Alendronate—osteoporosis	0.000144	0.000828	CcSEcCtD
Indomethacin—Hypersensitivity—Ibandronate—osteoporosis	0.000144	0.000828	CcSEcCtD
Indomethacin—Dyspnoea—Risedronate—osteoporosis	0.000144	0.000825	CcSEcCtD
Indomethacin—Erythema multiforme—Estradiol—osteoporosis	0.000144	0.000825	CcSEcCtD
Indomethacin—Hypotension—Pamidronate—osteoporosis	0.000143	0.000822	CcSEcCtD
Indomethacin—Convulsion—Conjugated Estrogens—osteoporosis	0.000143	0.000822	CcSEcCtD
Indomethacin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000143	0.000819	CcSEcCtD
Indomethacin—Pruritus—Alendronate—osteoporosis	0.000142	0.000816	CcSEcCtD
Indomethacin—Dyspepsia—Risedronate—osteoporosis	0.000142	0.000815	CcSEcCtD
Indomethacin—Tinnitus—Estradiol—osteoporosis	0.000142	0.000813	CcSEcCtD
Indomethacin—Constipation—Ethinyl Estradiol—osteoporosis	0.000142	0.000812	CcSEcCtD
Indomethacin—Confusional state—Zoledronate—osteoporosis	0.000141	0.000811	CcSEcCtD
Indomethacin—Hypersensitivity—Calcitriol—osteoporosis	0.000141	0.00081	CcSEcCtD
Indomethacin—Flushing—Estradiol—osteoporosis	0.000141	0.000809	CcSEcCtD
Indomethacin—Chest pain—Conjugated Estrogens—osteoporosis	0.000141	0.000808	CcSEcCtD
Indomethacin—Asthenia—Ibandronate—osteoporosis	0.000141	0.000806	CcSEcCtD
Indomethacin—Anxiety—Conjugated Estrogens—osteoporosis	0.00014	0.000805	CcSEcCtD
Indomethacin—Nausea—Etidronic acid—osteoporosis	0.00014	0.000804	CcSEcCtD
Indomethacin—Oedema—Zoledronate—osteoporosis	0.00014	0.000804	CcSEcCtD
Indomethacin—Anaphylactic shock—Zoledronate—osteoporosis	0.00014	0.000804	CcSEcCtD
Indomethacin—Diarrhoea—Estropipate—osteoporosis	0.00014	0.000802	CcSEcCtD
Indomethacin—Fatigue—Risedronate—osteoporosis	0.000139	0.000798	CcSEcCtD
Indomethacin—Insomnia—Pamidronate—osteoporosis	0.000139	0.000796	CcSEcCtD
Indomethacin—Pruritus—Ibandronate—osteoporosis	0.000139	0.000795	CcSEcCtD
Indomethacin—Pain—Risedronate—osteoporosis	0.000138	0.000792	CcSEcCtD
Indomethacin—Constipation—Risedronate—osteoporosis	0.000138	0.000792	CcSEcCtD
Indomethacin—Shock—Zoledronate—osteoporosis	0.000138	0.000791	CcSEcCtD
Indomethacin—Paraesthesia—Pamidronate—osteoporosis	0.000138	0.00079	CcSEcCtD
Indomethacin—Diarrhoea—Alendronate—osteoporosis	0.000138	0.00079	CcSEcCtD
Indomethacin—Asthenia—Calcitriol—osteoporosis	0.000138	0.000789	CcSEcCtD
Indomethacin—Thrombocytopenia—Zoledronate—osteoporosis	0.000137	0.000787	CcSEcCtD
Indomethacin—Dyspnoea—Pamidronate—osteoporosis	0.000137	0.000785	CcSEcCtD
Indomethacin—Tachycardia—Zoledronate—osteoporosis	0.000137	0.000785	CcSEcCtD
Indomethacin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000136	0.000783	CcSEcCtD
Indomethacin—Somnolence—Pamidronate—osteoporosis	0.000136	0.000782	CcSEcCtD
Indomethacin—Pruritus—Calcitriol—osteoporosis	0.000136	0.000778	CcSEcCtD
Indomethacin—Hyperhidrosis—Zoledronate—osteoporosis	0.000136	0.000777	CcSEcCtD
Indomethacin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000135	0.000777	CcSEcCtD
Indomethacin—Diarrhoea—Raloxifene—osteoporosis	0.000135	0.000777	CcSEcCtD
Indomethacin—Dyspepsia—Pamidronate—osteoporosis	0.000135	0.000775	CcSEcCtD
Indomethacin—Dizziness—Estropipate—osteoporosis	0.000135	0.000775	CcSEcCtD
Indomethacin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000135	0.000774	CcSEcCtD
Indomethacin—Oedema—Conjugated Estrogens—osteoporosis	0.000135	0.000774	CcSEcCtD
Indomethacin—Alopecia—Estradiol—osteoporosis	0.000134	0.000771	CcSEcCtD
Indomethacin—Diarrhoea—Ibandronate—osteoporosis	0.000134	0.000769	CcSEcCtD
Indomethacin—Anorexia—Zoledronate—osteoporosis	0.000134	0.000766	CcSEcCtD
Indomethacin—Decreased appetite—Pamidronate—osteoporosis	0.000133	0.000765	CcSEcCtD
Indomethacin—Dizziness—Alendronate—osteoporosis	0.000133	0.000763	CcSEcCtD
Indomethacin—Shock—Conjugated Estrogens—osteoporosis	0.000133	0.000762	CcSEcCtD
Indomethacin—Erythema—Estradiol—osteoporosis	0.000132	0.000759	CcSEcCtD
Indomethacin—Fatigue—Pamidronate—osteoporosis	0.000132	0.000759	CcSEcCtD
Indomethacin—Gastrointestinal pain—Risedronate—osteoporosis	0.000132	0.000757	CcSEcCtD
Indomethacin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000132	0.000756	CcSEcCtD
Indomethacin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000132	0.000754	CcSEcCtD
Indomethacin—Pain—Pamidronate—osteoporosis	0.000131	0.000753	CcSEcCtD
Indomethacin—Constipation—Pamidronate—osteoporosis	0.000131	0.000753	CcSEcCtD
Indomethacin—Diarrhoea—Calcitriol—osteoporosis	0.000131	0.000753	CcSEcCtD
Indomethacin—Hypotension—Zoledronate—osteoporosis	0.000131	0.000751	CcSEcCtD
Indomethacin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000131	0.000751	CcSEcCtD
Indomethacin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000131	0.000751	CcSEcCtD
Indomethacin—Dizziness—Raloxifene—osteoporosis	0.000131	0.00075	CcSEcCtD
Indomethacin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000131	0.000748	CcSEcCtD
Indomethacin—Flatulence—Estradiol—osteoporosis	0.00013	0.000748	CcSEcCtD
Indomethacin—Tension—Estradiol—osteoporosis	0.00013	0.000745	CcSEcCtD
Indomethacin—Vomiting—Estropipate—osteoporosis	0.00013	0.000745	CcSEcCtD
Indomethacin—Dizziness—Ibandronate—osteoporosis	0.00013	0.000743	CcSEcCtD
Indomethacin—Rash—Estropipate—osteoporosis	0.000129	0.000739	CcSEcCtD
Indomethacin—Dermatitis—Estropipate—osteoporosis	0.000129	0.000738	CcSEcCtD
Indomethacin—Anorexia—Conjugated Estrogens—osteoporosis	0.000129	0.000738	CcSEcCtD
Indomethacin—Nervousness—Estradiol—osteoporosis	0.000129	0.000737	CcSEcCtD
Indomethacin—Urticaria—Risedronate—osteoporosis	0.000128	0.000736	CcSEcCtD
Indomethacin—Headache—Estropipate—osteoporosis	0.000128	0.000734	CcSEcCtD
Indomethacin—Vomiting—Alendronate—osteoporosis	0.000128	0.000734	CcSEcCtD
Indomethacin—Body temperature increased—Risedronate—osteoporosis	0.000128	0.000732	CcSEcCtD
Indomethacin—Abdominal pain—Risedronate—osteoporosis	0.000128	0.000732	CcSEcCtD
Indomethacin—Rash—Alendronate—osteoporosis	0.000127	0.000728	CcSEcCtD
Indomethacin—Insomnia—Zoledronate—osteoporosis	0.000127	0.000727	CcSEcCtD
Indomethacin—Dermatitis—Alendronate—osteoporosis	0.000127	0.000727	CcSEcCtD
Indomethacin—Feeling abnormal—Pamidronate—osteoporosis	0.000126	0.000725	CcSEcCtD
Indomethacin—Hypotension—Conjugated Estrogens—osteoporosis	0.000126	0.000723	CcSEcCtD
Indomethacin—Headache—Alendronate—osteoporosis	0.000126	0.000723	CcSEcCtD
Indomethacin—Paraesthesia—Zoledronate—osteoporosis	0.000126	0.000722	CcSEcCtD
Indomethacin—Vomiting—Raloxifene—osteoporosis	0.000126	0.000722	CcSEcCtD
Indomethacin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000126	0.00072	CcSEcCtD
Indomethacin—Dyspnoea—Zoledronate—osteoporosis	0.000125	0.000717	CcSEcCtD
Indomethacin—Rash—Raloxifene—osteoporosis	0.000125	0.000716	CcSEcCtD
Indomethacin—Dermatitis—Raloxifene—osteoporosis	0.000125	0.000715	CcSEcCtD
Indomethacin—Somnolence—Zoledronate—osteoporosis	0.000125	0.000715	CcSEcCtD
Indomethacin—Vomiting—Ibandronate—osteoporosis	0.000125	0.000714	CcSEcCtD
Indomethacin—Headache—Raloxifene—osteoporosis	0.000124	0.000711	CcSEcCtD
Indomethacin—Rash—Ibandronate—osteoporosis	0.000124	0.000708	CcSEcCtD
Indomethacin—Dermatitis—Ibandronate—osteoporosis	0.000123	0.000708	CcSEcCtD
Indomethacin—Dyspepsia—Zoledronate—osteoporosis	0.000123	0.000708	CcSEcCtD
Indomethacin—Ill-defined disorder—Estradiol—osteoporosis	0.000123	0.000704	CcSEcCtD
Indomethacin—Headache—Ibandronate—osteoporosis	0.000123	0.000704	CcSEcCtD
Indomethacin—Insomnia—Conjugated Estrogens—osteoporosis	0.000122	0.0007	CcSEcCtD
Indomethacin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000122	0.0007	CcSEcCtD
Indomethacin—Vomiting—Calcitriol—osteoporosis	0.000122	0.000699	CcSEcCtD
Indomethacin—Decreased appetite—Zoledronate—osteoporosis	0.000122	0.000699	CcSEcCtD
Indomethacin—Nausea—Estropipate—osteoporosis	0.000121	0.000696	CcSEcCtD
Indomethacin—Body temperature increased—Pamidronate—osteoporosis	0.000121	0.000696	CcSEcCtD
Indomethacin—Abdominal pain—Pamidronate—osteoporosis	0.000121	0.000696	CcSEcCtD
Indomethacin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000121	0.000695	CcSEcCtD
Indomethacin—Angioedema—Estradiol—osteoporosis	0.000121	0.000694	CcSEcCtD
Indomethacin—Rash—Calcitriol—osteoporosis	0.000121	0.000693	CcSEcCtD
Indomethacin—Fatigue—Zoledronate—osteoporosis	0.000121	0.000693	CcSEcCtD
Indomethacin—Dermatitis—Calcitriol—osteoporosis	0.000121	0.000693	CcSEcCtD
Indomethacin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00012	0.00069	CcSEcCtD
Indomethacin—Headache—Calcitriol—osteoporosis	0.00012	0.000689	CcSEcCtD
Indomethacin—Somnolence—Conjugated Estrogens—osteoporosis	0.00012	0.000688	CcSEcCtD
Indomethacin—Pain—Zoledronate—osteoporosis	0.00012	0.000688	CcSEcCtD
Indomethacin—Constipation—Zoledronate—osteoporosis	0.00012	0.000688	CcSEcCtD
Indomethacin—Nausea—Alendronate—osteoporosis	0.00012	0.000685	CcSEcCtD
Indomethacin—Malaise—Estradiol—osteoporosis	0.000119	0.000685	CcSEcCtD
Indomethacin—Hypersensitivity—Risedronate—osteoporosis	0.000119	0.000682	CcSEcCtD
Indomethacin—Vertigo—Estradiol—osteoporosis	0.000119	0.000682	CcSEcCtD
Indomethacin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000119	0.000681	CcSEcCtD
Indomethacin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000119	0.000681	CcSEcCtD
Indomethacin—Syncope—Estradiol—osteoporosis	0.000119	0.000681	CcSEcCtD
Indomethacin—Nausea—Raloxifene—osteoporosis	0.000118	0.000674	CcSEcCtD
Indomethacin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000117	0.000673	CcSEcCtD
Indomethacin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000117	0.000672	CcSEcCtD
Indomethacin—Palpitations—Estradiol—osteoporosis	0.000117	0.000671	CcSEcCtD
Indomethacin—Fatigue—Conjugated Estrogens—osteoporosis	0.000116	0.000667	CcSEcCtD
Indomethacin—Nausea—Ibandronate—osteoporosis	0.000116	0.000667	CcSEcCtD
Indomethacin—Loss of consciousness—Estradiol—osteoporosis	0.000116	0.000667	CcSEcCtD
Indomethacin—Asthenia—Risedronate—osteoporosis	0.000116	0.000664	CcSEcCtD
Indomethacin—Feeling abnormal—Zoledronate—osteoporosis	0.000116	0.000663	CcSEcCtD
Indomethacin—Pain—Conjugated Estrogens—osteoporosis	0.000115	0.000662	CcSEcCtD
Indomethacin—Constipation—Conjugated Estrogens—osteoporosis	0.000115	0.000662	CcSEcCtD
Indomethacin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000115	0.000657	CcSEcCtD
Indomethacin—Hypertension—Estradiol—osteoporosis	0.000114	0.000655	CcSEcCtD
Indomethacin—Pruritus—Risedronate—osteoporosis	0.000114	0.000655	CcSEcCtD
Indomethacin—Nausea—Calcitriol—osteoporosis	0.000114	0.000653	CcSEcCtD
Indomethacin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000113	0.00065	CcSEcCtD
Indomethacin—Hypersensitivity—Pamidronate—osteoporosis	0.000113	0.000648	CcSEcCtD
Indomethacin—Chest pain—Estradiol—osteoporosis	0.000113	0.000646	CcSEcCtD
Indomethacin—Anxiety—Estradiol—osteoporosis	0.000112	0.000644	CcSEcCtD
Indomethacin—Urticaria—Zoledronate—osteoporosis	0.000111	0.000639	CcSEcCtD
Indomethacin—Discomfort—Estradiol—osteoporosis	0.000111	0.000639	CcSEcCtD
Indomethacin—Abdominal pain—Zoledronate—osteoporosis	0.000111	0.000636	CcSEcCtD
Indomethacin—Body temperature increased—Zoledronate—osteoporosis	0.000111	0.000636	CcSEcCtD
Indomethacin—Diarrhoea—Risedronate—osteoporosis	0.00011	0.000634	CcSEcCtD
Indomethacin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00011	0.000633	CcSEcCtD
Indomethacin—Asthenia—Pamidronate—osteoporosis	0.00011	0.000632	CcSEcCtD
Indomethacin—Dizziness—Ethinyl Estradiol—osteoporosis	0.00011	0.000628	CcSEcCtD
Indomethacin—Confusional state—Estradiol—osteoporosis	0.000109	0.000625	CcSEcCtD
Indomethacin—Pruritus—Pamidronate—osteoporosis	0.000109	0.000623	CcSEcCtD
Indomethacin—Oedema—Estradiol—osteoporosis	0.000108	0.00062	CcSEcCtD
Indomethacin—Anaphylactic shock—Estradiol—osteoporosis	0.000108	0.00062	CcSEcCtD
Indomethacin—Urticaria—Conjugated Estrogens—osteoporosis	0.000107	0.000615	CcSEcCtD
Indomethacin—Dizziness—Risedronate—osteoporosis	0.000107	0.000612	CcSEcCtD
Indomethacin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000107	0.000612	CcSEcCtD
Indomethacin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000107	0.000612	CcSEcCtD
Indomethacin—Shock—Estradiol—osteoporosis	0.000106	0.00061	CcSEcCtD
Indomethacin—Tachycardia—Estradiol—osteoporosis	0.000105	0.000605	CcSEcCtD
Indomethacin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000105	0.000604	CcSEcCtD
Indomethacin—Diarrhoea—Pamidronate—osteoporosis	0.000105	0.000602	CcSEcCtD
Indomethacin—Hyperhidrosis—Estradiol—osteoporosis	0.000104	0.000599	CcSEcCtD
Indomethacin—Rash—Ethinyl Estradiol—osteoporosis	0.000104	0.000599	CcSEcCtD
Indomethacin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000104	0.000598	CcSEcCtD
Indomethacin—Headache—Ethinyl Estradiol—osteoporosis	0.000104	0.000595	CcSEcCtD
Indomethacin—Hypersensitivity—Zoledronate—osteoporosis	0.000103	0.000592	CcSEcCtD
Indomethacin—Vomiting—Risedronate—osteoporosis	0.000103	0.000589	CcSEcCtD
Indomethacin—Rash—Risedronate—osteoporosis	0.000102	0.000584	CcSEcCtD
Indomethacin—Dermatitis—Risedronate—osteoporosis	0.000102	0.000583	CcSEcCtD
Indomethacin—Dizziness—Pamidronate—osteoporosis	0.000101	0.000582	CcSEcCtD
Indomethacin—Headache—Risedronate—osteoporosis	0.000101	0.00058	CcSEcCtD
Indomethacin—Asthenia—Zoledronate—osteoporosis	0.000101	0.000577	CcSEcCtD
Indomethacin—Hypersensitivity—Conjugated Estrogens—osteoporosis	9.95e-05	0.00057	CcSEcCtD
Indomethacin—Pruritus—Zoledronate—osteoporosis	9.92e-05	0.000569	CcSEcCtD
Indomethacin—Nausea—Ethinyl Estradiol—osteoporosis	9.84e-05	0.000564	CcSEcCtD
Indomethacin—Insomnia—Estradiol—osteoporosis	9.77e-05	0.00056	CcSEcCtD
Indomethacin—Vomiting—Pamidronate—osteoporosis	9.76e-05	0.00056	CcSEcCtD
Indomethacin—Paraesthesia—Estradiol—osteoporosis	9.7e-05	0.000556	CcSEcCtD
Indomethacin—Asthenia—Conjugated Estrogens—osteoporosis	9.69e-05	0.000555	CcSEcCtD
Indomethacin—Rash—Pamidronate—osteoporosis	9.68e-05	0.000555	CcSEcCtD
Indomethacin—Dermatitis—Pamidronate—osteoporosis	9.67e-05	0.000554	CcSEcCtD
Indomethacin—Dyspnoea—Estradiol—osteoporosis	9.63e-05	0.000552	CcSEcCtD
Indomethacin—Headache—Pamidronate—osteoporosis	9.62e-05	0.000551	CcSEcCtD
Indomethacin—Somnolence—Estradiol—osteoporosis	9.6e-05	0.000551	CcSEcCtD
Indomethacin—Diarrhoea—Zoledronate—osteoporosis	9.59e-05	0.00055	CcSEcCtD
Indomethacin—Nausea—Risedronate—osteoporosis	9.59e-05	0.00055	CcSEcCtD
Indomethacin—Pruritus—Conjugated Estrogens—osteoporosis	9.55e-05	0.000548	CcSEcCtD
Indomethacin—Dyspepsia—Estradiol—osteoporosis	9.51e-05	0.000545	CcSEcCtD
Indomethacin—Decreased appetite—Estradiol—osteoporosis	9.39e-05	0.000539	CcSEcCtD
Indomethacin—Fatigue—Estradiol—osteoporosis	9.31e-05	0.000534	CcSEcCtD
Indomethacin—Dizziness—Zoledronate—osteoporosis	9.27e-05	0.000532	CcSEcCtD
Indomethacin—Pain—Estradiol—osteoporosis	9.24e-05	0.00053	CcSEcCtD
Indomethacin—Constipation—Estradiol—osteoporosis	9.24e-05	0.00053	CcSEcCtD
Indomethacin—Diarrhoea—Conjugated Estrogens—osteoporosis	9.24e-05	0.00053	CcSEcCtD
Indomethacin—Nausea—Pamidronate—osteoporosis	9.12e-05	0.000523	CcSEcCtD
Indomethacin—Dizziness—Conjugated Estrogens—osteoporosis	8.93e-05	0.000512	CcSEcCtD
Indomethacin—Vomiting—Zoledronate—osteoporosis	8.91e-05	0.000511	CcSEcCtD
Indomethacin—Feeling abnormal—Estradiol—osteoporosis	8.9e-05	0.000511	CcSEcCtD
Indomethacin—Rash—Zoledronate—osteoporosis	8.84e-05	0.000507	CcSEcCtD
Indomethacin—Gastrointestinal pain—Estradiol—osteoporosis	8.83e-05	0.000507	CcSEcCtD
Indomethacin—Dermatitis—Zoledronate—osteoporosis	8.83e-05	0.000506	CcSEcCtD
Indomethacin—Headache—Zoledronate—osteoporosis	8.78e-05	0.000504	CcSEcCtD
Indomethacin—Vomiting—Conjugated Estrogens—osteoporosis	8.58e-05	0.000492	CcSEcCtD
Indomethacin—Urticaria—Estradiol—osteoporosis	8.58e-05	0.000492	CcSEcCtD
Indomethacin—Abdominal pain—Estradiol—osteoporosis	8.54e-05	0.00049	CcSEcCtD
Indomethacin—Body temperature increased—Estradiol—osteoporosis	8.54e-05	0.00049	CcSEcCtD
Indomethacin—Rash—Conjugated Estrogens—osteoporosis	8.51e-05	0.000488	CcSEcCtD
Indomethacin—Dermatitis—Conjugated Estrogens—osteoporosis	8.5e-05	0.000488	CcSEcCtD
Indomethacin—Headache—Conjugated Estrogens—osteoporosis	8.46e-05	0.000485	CcSEcCtD
Indomethacin—Nausea—Zoledronate—osteoporosis	8.33e-05	0.000478	CcSEcCtD
Indomethacin—Nausea—Conjugated Estrogens—osteoporosis	8.02e-05	0.00046	CcSEcCtD
Indomethacin—Hypersensitivity—Estradiol—osteoporosis	7.96e-05	0.000456	CcSEcCtD
Indomethacin—Asthenia—Estradiol—osteoporosis	7.75e-05	0.000445	CcSEcCtD
Indomethacin—Pruritus—Estradiol—osteoporosis	7.64e-05	0.000438	CcSEcCtD
Indomethacin—Diarrhoea—Estradiol—osteoporosis	7.39e-05	0.000424	CcSEcCtD
Indomethacin—Dizziness—Estradiol—osteoporosis	7.14e-05	0.00041	CcSEcCtD
Indomethacin—Vomiting—Estradiol—osteoporosis	6.87e-05	0.000394	CcSEcCtD
Indomethacin—Rash—Estradiol—osteoporosis	6.81e-05	0.000391	CcSEcCtD
Indomethacin—Dermatitis—Estradiol—osteoporosis	6.81e-05	0.00039	CcSEcCtD
Indomethacin—Headache—Estradiol—osteoporosis	6.77e-05	0.000388	CcSEcCtD
Indomethacin—Nausea—Estradiol—osteoporosis	6.42e-05	0.000368	CcSEcCtD
Indomethacin—PPARG—Gene Expression—VDR—osteoporosis	1.37e-05	0.000126	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.36e-05	0.000125	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GAPDH—osteoporosis	1.36e-05	0.000124	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KL—osteoporosis	1.35e-05	0.000124	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ADCY5—osteoporosis	1.34e-05	0.000123	CbGpPWpGaD
Indomethacin—ALB—Metabolism—OXCT1—osteoporosis	1.34e-05	0.000123	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CA2—osteoporosis	1.34e-05	0.000123	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—RAP1A—osteoporosis	1.32e-05	0.000121	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—POMC—osteoporosis	1.32e-05	0.000121	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ENO1—osteoporosis	1.31e-05	0.00012	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ENO1—osteoporosis	1.31e-05	0.00012	CbGpPWpGaD
Indomethacin—PTGS2—Disease—P4HB—osteoporosis	1.31e-05	0.00012	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MGLL—osteoporosis	1.31e-05	0.00012	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SPP1—osteoporosis	1.3e-05	0.000119	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.3e-05	0.000119	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PSMA5—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PSMA2—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PSMA5—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PSMA2—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP27A1—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PNP—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ATIC—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CYP19A1—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CYP19A1—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—PTGS2—Disease—GAPDH—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6R—osteoporosis	1.29e-05	0.000118	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—MTHFR—osteoporosis	1.28e-05	0.000117	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.27e-05	0.000116	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ENO1—osteoporosis	1.27e-05	0.000116	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.26e-05	0.000116	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KL—osteoporosis	1.26e-05	0.000115	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ACP5—osteoporosis	1.26e-05	0.000115	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PSMA2—osteoporosis	1.25e-05	0.000114	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PSMA5—osteoporosis	1.25e-05	0.000114	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.24e-05	0.000114	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.23e-05	0.000113	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NFATC1—osteoporosis	1.22e-05	0.000112	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CYP19A1—osteoporosis	1.22e-05	0.000112	CbGpPWpGaD
Indomethacin—PTGS2—Disease—DKK1—osteoporosis	1.21e-05	0.000111	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CA2—osteoporosis	1.2e-05	0.00011	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—OXCT1—osteoporosis	1.2e-05	0.00011	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ENO1—osteoporosis	1.2e-05	0.00011	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PSMA5—osteoporosis	1.18e-05	0.000109	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PSMA2—osteoporosis	1.18e-05	0.000109	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.18e-05	0.000108	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—POMC—osteoporosis	1.18e-05	0.000108	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CA2—osteoporosis	1.18e-05	0.000108	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—OXCT1—osteoporosis	1.18e-05	0.000108	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IRS2—osteoporosis	1.17e-05	0.000108	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MGLL—osteoporosis	1.17e-05	0.000108	CbGpPWpGaD
Indomethacin—PTGS2—Disease—WNT1—osteoporosis	1.17e-05	0.000107	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TPI1—osteoporosis	1.17e-05	0.000107	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MYC—osteoporosis	1.16e-05	0.000106	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.15e-05	0.000106	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TGFB1—osteoporosis	1.15e-05	0.000106	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—LEP—osteoporosis	1.15e-05	0.000105	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MGLL—osteoporosis	1.15e-05	0.000105	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGA—osteoporosis	1.14e-05	0.000104	CbGpPWpGaD
Indomethacin—PPARG—Generic Transcription Pathway—MYC—osteoporosis	1.13e-05	0.000104	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CYP19A1—osteoporosis	1.12e-05	0.000103	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—IL6—osteoporosis	1.12e-05	0.000102	CbGpPWpGaD
Indomethacin—ALB—Metabolism—IDH2—osteoporosis	1.11e-05	0.000102	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.11e-05	0.000101	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—P4HB—osteoporosis	1.1e-05	0.000101	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—OXCT1—osteoporosis	1.1e-05	0.000101	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CA2—osteoporosis	1.1e-05	0.000101	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ESR1—osteoporosis	1.1e-05	0.000101	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GAPDH—osteoporosis	1.08e-05	9.88e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MGLL—osteoporosis	1.07e-05	9.81e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ENO1—osteoporosis	1.07e-05	9.8e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TGFB1—osteoporosis	1.06e-05	9.75e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ADCY5—osteoporosis	1.06e-05	9.7e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ADCY5—osteoporosis	1.05e-05	9.66e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ADCY5—osteoporosis	1.05e-05	9.66e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PSMA2—osteoporosis	1.05e-05	9.66e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PSMA5—osteoporosis	1.05e-05	9.66e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—GPX1—osteoporosis	1.05e-05	9.63e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—GPX1—osteoporosis	1.05e-05	9.63e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—RAP1A—osteoporosis	1.05e-05	9.62e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CYP19A1—osteoporosis	1.05e-05	9.61e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CYP19A1—osteoporosis	1.05e-05	9.61e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—ESR1—osteoporosis	1.05e-05	9.61e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP27A1—osteoporosis	1.05e-05	9.58e-05	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TGFB1—osteoporosis	1.04e-05	9.51e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IRS1—osteoporosis	1.03e-05	9.39e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SPP1—osteoporosis	1.02e-05	9.39e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—POMC—osteoporosis	1.02e-05	9.38e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ACP5—osteoporosis	1.02e-05	9.32e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ENO1—osteoporosis	1.01e-05	9.29e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CYP19A1—osteoporosis	1.01e-05	9.27e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.01e-05	9.25e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1e-05	9.2e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PSMA2—osteoporosis	9.99e-06	9.15e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PSMA5—osteoporosis	9.99e-06	9.15e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—IDH2—osteoporosis	9.98e-06	9.15e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ADCY5—osteoporosis	9.97e-06	9.14e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GPX1—osteoporosis	9.94e-06	9.11e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TNF—osteoporosis	9.93e-06	9.1e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—POMC—osteoporosis	9.87e-06	9.05e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ADCY5—osteoporosis	9.87e-06	9.04e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—IDH2—osteoporosis	9.74e-06	8.93e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—MTHFR—osteoporosis	9.7e-06	8.89e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—MTHFR—osteoporosis	9.7e-06	8.89e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6R—osteoporosis	9.63e-06	8.82e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CYP19A1—osteoporosis	9.61e-06	8.81e-05	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.58e-06	8.78e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IGF1—osteoporosis	9.5e-06	8.7e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TPI1—osteoporosis	9.45e-06	8.66e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP27A1—osteoporosis	9.38e-06	8.6e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CALCA—osteoporosis	9.31e-06	8.53e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IRS2—osteoporosis	9.26e-06	8.49e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ADCY5—osteoporosis	9.18e-06	8.42e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—MTHFR—osteoporosis	9.17e-06	8.4e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.16e-06	8.39e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP27A1—osteoporosis	9.16e-06	8.39e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GPX1—osteoporosis	9.15e-06	8.39e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ACP5—osteoporosis	9.13e-06	8.37e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	9.11e-06	8.34e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—IDH2—osteoporosis	9.1e-06	8.34e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MTHFR—osteoporosis	9.07e-06	8.32e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—LEP—osteoporosis	9.06e-06	8.31e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.01e-06	8.26e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	8.99e-06	8.24e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	8.97e-06	8.22e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ACP5—osteoporosis	8.91e-06	8.16e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—P4HB—osteoporosis	8.89e-06	8.15e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GAPDH—osteoporosis	8.72e-06	8e-05	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL6—osteoporosis	8.68e-06	7.96e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ESR1—osteoporosis	8.65e-06	7.93e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IRS2—osteoporosis	8.63e-06	7.91e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ADCY5—osteoporosis	8.57e-06	7.85e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ADCY5—osteoporosis	8.57e-06	7.85e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP27A1—osteoporosis	8.56e-06	7.84e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CYP19A1—osteoporosis	8.55e-06	7.84e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GPX1—osteoporosis	8.54e-06	7.83e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GPX1—osteoporosis	8.54e-06	7.83e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—RAP1A—osteoporosis	8.5e-06	7.79e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ENO1—osteoporosis	8.49e-06	7.78e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TPI1—osteoporosis	8.49e-06	7.78e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KL—osteoporosis	8.45e-06	7.75e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—MTHFR—osteoporosis	8.45e-06	7.74e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.39e-06	7.69e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.37e-06	7.67e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PSMA2—osteoporosis	8.37e-06	7.67e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PSMA5—osteoporosis	8.37e-06	7.67e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ACP5—osteoporosis	8.32e-06	7.63e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TPI1—osteoporosis	8.28e-06	7.59e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ADCY5—osteoporosis	8.26e-06	7.57e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GPX1—osteoporosis	8.24e-06	7.55e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.22e-06	7.53e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MYC—osteoporosis	8.15e-06	7.47e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TGFB1—osteoporosis	8.13e-06	7.45e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IRS1—osteoporosis	8.09e-06	7.41e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—IL6—osteoporosis	8.01e-06	7.34e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—P4HB—osteoporosis	7.98e-06	7.31e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—MTHFR—osteoporosis	7.88e-06	7.22e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—MTHFR—osteoporosis	7.88e-06	7.22e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ADCY5—osteoporosis	7.85e-06	7.2e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GAPDH—osteoporosis	7.83e-06	7.18e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IGF1—osteoporosis	7.83e-06	7.17e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GPX1—osteoporosis	7.83e-06	7.17e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—P4HB—osteoporosis	7.79e-06	7.14e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—POMC—osteoporosis	7.79e-06	7.14e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—POMC—osteoporosis	7.76e-06	7.11e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—POMC—osteoporosis	7.76e-06	7.11e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TPI1—osteoporosis	7.74e-06	7.09e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GAPDH—osteoporosis	7.64e-06	7.01e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—RAP1A—osteoporosis	7.63e-06	6.99e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—MYC—osteoporosis	7.61e-06	6.97e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—MTHFR—osteoporosis	7.6e-06	6.96e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6R—osteoporosis	7.6e-06	6.96e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IRS1—osteoporosis	7.54e-06	6.91e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IGF1—osteoporosis	7.49e-06	6.86e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—RAP1A—osteoporosis	7.45e-06	6.82e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.41e-06	6.79e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—POMC—osteoporosis	7.34e-06	6.72e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—P4HB—osteoporosis	7.28e-06	6.67e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—MTHFR—osteoporosis	7.22e-06	6.62e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GAPDH—osteoporosis	7.14e-06	6.54e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6R—osteoporosis	7.08e-06	6.49e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ADCY5—osteoporosis	6.99e-06	6.4e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GPX1—osteoporosis	6.96e-06	6.38e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—RAP1A—osteoporosis	6.96e-06	6.37e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ENO1—osteoporosis	6.87e-06	6.29e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP19A1—osteoporosis	6.79e-06	6.22e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PSMA2—osteoporosis	6.77e-06	6.2e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PSMA5—osteoporosis	6.77e-06	6.2e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—POMC—osteoporosis	6.75e-06	6.19e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.65e-06	6.1e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ADCY5—osteoporosis	6.62e-06	6.07e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—MTHFR—osteoporosis	6.43e-06	5.89e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—POMC—osteoporosis	6.3e-06	5.78e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—POMC—osteoporosis	6.3e-06	5.78e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ENO1—osteoporosis	6.17e-06	5.65e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—osteoporosis	6.13e-06	5.61e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTHFR—osteoporosis	6.09e-06	5.58e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—POMC—osteoporosis	6.08e-06	5.57e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PSMA2—osteoporosis	6.08e-06	5.57e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PSMA5—osteoporosis	6.08e-06	5.57e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.07e-06	5.56e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ENO1—osteoporosis	6.02e-06	5.52e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PSMA2—osteoporosis	5.93e-06	5.43e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PSMA5—osteoporosis	5.93e-06	5.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IRS2—osteoporosis	5.79e-06	5.31e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—POMC—osteoporosis	5.78e-06	5.29e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—osteoporosis	5.73e-06	5.25e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—osteoporosis	5.71e-06	5.23e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—osteoporosis	5.69e-06	5.22e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ENO1—osteoporosis	5.62e-06	5.15e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ADCY5—osteoporosis	5.55e-06	5.08e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PSMA2—osteoporosis	5.54e-06	5.08e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PSMA5—osteoporosis	5.54e-06	5.08e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GPX1—osteoporosis	5.53e-06	5.06e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP19A1—osteoporosis	5.49e-06	5.03e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—osteoporosis	5.45e-06	5e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—POMC—osteoporosis	5.14e-06	4.71e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—osteoporosis	5.1e-06	4.67e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IRS1—osteoporosis	5.06e-06	4.64e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP19A1—osteoporosis	4.93e-06	4.52e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP19A1—osteoporosis	4.81e-06	4.41e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6R—osteoporosis	4.75e-06	4.35e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—osteoporosis	4.69e-06	4.3e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—osteoporosis	4.5e-06	4.12e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP19A1—osteoporosis	4.49e-06	4.12e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—osteoporosis	4.49e-06	4.11e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ADCY5—osteoporosis	4.49e-06	4.11e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GPX1—osteoporosis	4.47e-06	4.1e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—osteoporosis	4.29e-06	3.93e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—osteoporosis	4.2e-06	3.84e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—osteoporosis	4.19e-06	3.84e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—osteoporosis	4.13e-06	3.78e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—POMC—osteoporosis	4.08e-06	3.74e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ADCY5—osteoporosis	4.03e-06	3.69e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GPX1—osteoporosis	4.01e-06	3.68e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ADCY5—osteoporosis	3.93e-06	3.6e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GPX1—osteoporosis	3.92e-06	3.59e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—osteoporosis	3.7e-06	3.39e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ADCY5—osteoporosis	3.67e-06	3.37e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GPX1—osteoporosis	3.66e-06	3.35e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—osteoporosis	3.62e-06	3.31e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—osteoporosis	3.38e-06	3.1e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—osteoporosis	3.38e-06	3.1e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—POMC—osteoporosis	3.3e-06	3.02e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—osteoporosis	3.15e-06	2.89e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—POMC—osteoporosis	2.96e-06	2.71e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—POMC—osteoporosis	2.89e-06	2.65e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—osteoporosis	2.82e-06	2.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—osteoporosis	2.81e-06	2.57e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—POMC—osteoporosis	2.7e-06	2.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—osteoporosis	2.12e-06	1.94e-05	CbGpPWpGaD
